Basic Information
| LncRNA/CircRNA Name | circ_5692 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR, methylation-specific PCR, MTT assay, wound-healing assay, transwell invasion assay, flow cytometry and Western blotting. |
| Sample | liver cancer tissues and cell lines |
| Expression Pattern | down-regulated |
| Function Description | CircRNA-5692 expression was downregulated in HCC tissues, and circRNA-5692 overexpression attenuated the malignant behaviors of HCC cells. |
| Pubmed ID | 31776329 |
| Year | 2019 |
| Title | CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression |
External Links
| Links for circ_5692 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |